David Szekeres

2022

In 2022, David Szekeres earned a total compensation of $1.4M as Executive Vice President, Chief Commercial Officer at Heron Therapeutics, a 22% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$199,880
Option Awards$235,482
Salary$533,013
Stock Awards$441,456
Other$19,400
Total$1,429,231

Szekeres received $533K in salary, accounting for 37% of the total pay in 2022.

Szekeres also received $199.9K in non-equity incentive plan, $235.5K in option awards, $441.5K in stock awards and $19.4K in other compensation.

Rankings

In 2022, David Szekeres' compensation ranked 2,327th out of 5,759 executives tracked by ExecPay. In other words, Szekeres earned more than 59.6% of executives.

ClassificationRankingPercentile
All
2,327
out of 5,759
60th
Division
Manufacturing
1,266
out of 3,135
60th
Major group
Chemicals And Allied Products
566
out of 1,421
60th
Industry group
Drugs
521
out of 1,322
61st
Industry
Pharmaceutical Preparations
377
out of 968
61st
Source: SEC filing on May 1, 2023.

Szekeres' colleagues

We found two more compensation records of executives who worked with David Szekeres at Heron Therapeutics in 2022.

2022

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2022

Barry Quart

Heron Therapeutics

Chief Executive Officer

News

You may also like